EGFR and neoplasm: Well-established markers as therapeutic options in many tumours include the epidermal growth factor receptor (EGFR, ErbB), phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR and Ras/Raf/MAPK [9–11].